← All compounds
peptide31 listings
IGF-1 LR3
Long-Range Insulin-Like Growth Factor-1
Long-acting IGF-1 analog. Direct anabolic signaling.
Anabolic researchTissue research
/ research index
The research base
Research Maturity
★★★★☆
4/5 — Volume of studies
Evidence Strength
★★★★☆
4/5 — Quality of evidence
Extensively studied. Direct receptor activation downstream of GH.
/ mechanism of action
How it works
IGF-1 receptor agonist. Direct anabolic and proliferative signaling.
/ research dosing
Common research protocols
Range
20-50 mcg/day (research range; can go up to 100mcg)
Frequency
Once daily, AM
Route
Subcutaneous
Cycle
4 weeks on, 4+ weeks off (max 6 weeks continuous)
Research notes
Very potent IGF-1 analog with longer half-life (LR3 = Long R3). Risk of hypoglycemia — monitor blood sugar. Watch for tissue hyperplasia at high doses. Short cycles only. Should not be combined with insulin or other hypoglycemic agents.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Powerful standalone. Direct receptor activation.
/ side effects
What to know
Hypoglycemia possible. Generally well-tolerated at research doses.
/ timeline
Realistic expectations
1-2 weeks
/ recommendation
Where to buy IGF-1 LR3
🏆Our pick for IGF-1 LR3
Valor Peptides
1mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. IGF-1 LR3 is intended for laboratory research and not for human consumption.